Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

718 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of rituximab in hairy cell leukemia treatment.
Zinzani PL, Ascani S, Piccaluga PP, Bendandi M, Pileri S, Tura S. Zinzani PL, et al. Among authors: tura s. J Clin Oncol. 2000 Nov 15;18(22):3875-7. doi: 10.1200/JCO.2000.18.22.3875. J Clin Oncol. 2000. PMID: 11078503 No abstract available.
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma.
Zinzani PL, Pulsoni A, Perrotti A, Soverini S, Zaja F, De Renzo A, Storti S, Lauta VM, Guardigni L, Gentilini P, Tucci A, Molinari AL, Gobbi M, Falini B, Fattori PP, Ciccone F, Alinari L, Martelli M, Pileri S, Tura S, Baccarani M. Zinzani PL, et al. Among authors: tura s. J Clin Oncol. 2004 Jul 1;22(13):2654-61. doi: 10.1200/JCO.2004.07.170. Epub 2004 May 24. J Clin Oncol. 2004. PMID: 15159414 Clinical Trial.
2-Chlorodeoxyadenosine in psoriasis treatment.
Zinzani PL, Ricci P, Bendandi M, Tura S. Zinzani PL, et al. Among authors: tura s. Ann Oncol. 1995 May;6(5):509. doi: 10.1093/oxfordjournals.annonc.a059223. Ann Oncol. 1995. PMID: 7669715 Free article. No abstract available.
Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma.
Zinzani PL, Magagnoli M, Moretti L, De Renzo A, Battista R, Zaccaria A, Guardigni L, Mazza P, Marra R, Ronconi F, Lauta VM, Bendandi M, Gherlinzoni F, Gentilini P, Ciccone F, Cellini C, Stefoni V, Ricciuti F, Gobbi M, Tura S. Zinzani PL, et al. Among authors: tura s. J Clin Oncol. 2000 Feb;18(4):773-9. doi: 10.1200/JCO.2000.18.4.773. J Clin Oncol. 2000. PMID: 10673518 Clinical Trial.
718 results